5.4.2008 Official Journal of the European Union L 94/13 COMMISSION DIRECTIVE 2008/44/EC of 4 April 2008 amending Council Directive 91/414/EEC to include benthiavalicarb, boscalid, carvone, fluoxastrobin, Paecilomyces lilacinus and prothioconazole as active substances (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market ('), and in particular Article 6(1) thereof, Whereas: () O] L 230, 19.8.1991, p. 1. Commission Directive 2008/41/EC (O] L 89, 1.4.2008, p. 12). In accordance with Article 6(2) of Directive 91/414/EEC Belgium received on 19 April 2002 an application from Kumiai Chemicals Industry Co. Ltd for the inclusion of the active substance benthiavalicarb in Annex I to Directive 91/414/[EEC. Commission Decision 2003/35/EC (3 confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC. In accordance with Article 6(2) of Directive 91/414/EEC Germany received on 26 April 2001 an application from BASF AG for the inclusion of the active substance boscalid in Annex I to Directive 91/414/EEC. Commission Decision 2002/268/EC (}) confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and infor- mation requirements of Annexes I and III to Directive 91/414/EEC. In accordance with Article 6(2) of Directive 91/414/EEC the Netherlands received on 26 March 1997 an appli- cation from Luxan B.V. for the inclusion of the active substance carvone in Annex I to Directive 91/414/EEC. Commission Decision 1999/610/EC (* confirmed that the dossier was ‘complete’ in the sense that it could be Directive as last amended by () OJ L 11, 16.1.2003, p. 52. () O] L 92, 9.4.2002, p. 34. () O] L 242, 14.9.1999, p. 29. considered as satisfying, in principle, the data and infor- mation requirements of Annexes Il and III to Directive 91/414/[EEC. In accordance with Article 6(2) of Directive 91/414/EEC United Kingdom received on 25 March 2002 an appli- cation from Bayer AG for the inclusion of the active substance fluoxastrobin in Annex I to Directive 91/414/EEC. Decision 2003/35/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and infor- mation requirements of Annexes Il and III to Directive 91/414/EEC. In accordance with Article 6(2) of Directive 91/414/EEC Belgium received on 15 September 2002 an application from Prophyta for the inclusion of the active substance Paecilomyces lilacinus strain 251 (hereafter Paecilomyces lilacinus) in  Annex I to Directive 91/414/EEC. Commission Decision 2003/305/EC (°) confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and infor- mation requirements of Annexes Il and III to Directive 91/414/EEC. In accordance with Article 6(2) of Directive 91/414/EEC United Kingdom received on 25 March 2002 an appli- cation from Bayer CropScience for the inclusion of the active substance prothioconazole in Annex I to Directive 91/414/EEC. Decision 2003/35/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and infor- mation requirements of Annexes Il and III to Directive 91/414/EEC. For those active substances, the effects on human health and the environment have been assessed, in accordance with the provisions of Article 6(2) and (4) of Directive 91/414/[EEC, for the uses proposed by the applicants. The designated rapporteur Member States submitted draft assessment report on 13 April 2004 (benthiavalicarb), 22 November 2002 (boscalid), 16 October 2000 (carvone), 2 September 2003  (fluoxastrobin), 3 November 2004  (Paecilomyces lilacinus)  and 18 October 2004 (prothioconazole). () O] L 112, 6.5.2003, p. 10.